Evasion of Type I Interferon by SARS-CoV-2

Xia, Hongjie, Cao, Zengguo, Xie, Xuping, Zhang, Xianwen, Chen, John Yun-Chung, Wang, Hualei, Menachery, Vineet D., Rajsbaum, Ricardo +1 more·2020·Cell Reports

DOI 10.1016/j.celrep.2020.108234

Cited by (958)

Items 301–400 of 958

Viral infections and chronic rhinosinusitis
Sophia Volpe, Joseph D. Irish, Sunny Palumbo, Eric Lee, Jacob Ryan Herbert, Ibrahim Ramadan, Eugene H. Chang · 2023 · Journal of Allergy and Clinical Immunology
COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy
Mansoor Khaledi, Fatemeh Sameni, Sheida Yahyazade, Maedeh Radandish, Parviz Owlia, Nader Bagheri, Hamed Afkhami, Mohamad Mahjoor, Zahra Esmaelpour, Maryam Kohansal et al. · 2022 · Frontiers in Medicine
Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, Mithun Chakraborty · 2022 · European Journal of Medicinal Chemistry Reports
Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations
Marjahan Akhtar, Md. Rashedul Islam, Fatema Khaton, Umma Hany Soltana, Syeda Anoushka Jafrin, Sadia Isfat Ara Rahman, Imam Tauheed, Tasnuva Ahmed, Ishtiakul Islam Khan, Afroza Akter et al. · 2023 · Frontiers in Immunology
Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions
Masaud Shah, Hyun Goo Woo · 2021 · Molecules and Cells
Identification of intrinsically disorder regions in non-structural proteins of SARS-CoV-2: New insights into drug and vaccine resistance
Farah Anjum, Taj Mohammad, Purva Asrani, Alaa Shafie, Shailza Singh, Dharmendra Kumar Yadav, Vladimir Nikolaevich Uversky, Md. Imtaiyaz Hassan · 2022 · Molecular and Cellular Biochemistry
SARS-CoV-2 and the Nucleus
Mengqi Chen, Yue Ma, Wakam Chang · 2022 · International Journal of Biological Sciences
SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathways
Jian Deng, Shengnan Zheng, Yang Xiao, Mei‐Ling Nan, Jing Zhang, Lulu Han, Yi Zheng, Yanying Yu, Qiang Ding, Chengjiang Gao et al. · 2023 · Journal of Medical Virology
TRIM21 promotes ubiquitination of SARS‐CoV‐2 nucleocapsid protein to regulate innate immunity
Shenglan Mao, Xue-Fei Cai, Siqiang Niu, Jie Wei, Ning Jiang, Haijun Deng, Wen Wang, Jing Zhang, Shimei Shen, Yuanyan Ma et al. · 2023 · Journal of Medical Virology
An Update on Severe Acute Respiratory Syndrome Coronavirus 2 Diversity in the US National Capital Region: Evolution of Novel and Variants of Concern
C. Paul Morris, Chun Huai Luo, Adannaya Amadi, Matthew C. Schwartz, Nicholas Gallagher, Stuart C. Ray, Andrew S Pekosz, Heba H. Mostafa · 2021 · Clinical Infectious Diseases
Dysrupted microbial tryptophan metabolism associates with SARS-CoV-2 acute inflammatory responses and long COVID
Lu Yao, Hannah Devotta, Junhui Li, Nonhlanhla Lunjani, Corinna Sadlier, Aonghus Lavelle, Werner C. Albrich, Jens Walter, Paul William O’Toole, Liam O’Mahony · 2024 · Gut Microbes
Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 Virus Variant With Novel Genomic Architecture in Hong Kong
Herman Tse, David Christopher Lung, Sally C. Y. Wong, Ka-Fai Ip, Tak-Chiu Wu, Kelvin Kai‐Wang To, Kin‐Hang Kok, Kwok‐Yung Yuen, Garnet Kwan-Yue Choi · 2021 · Clinical Infectious Diseases
A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3′ Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity
Carlos Farkas, Andy Mella, Maxime Turgeon, Jody J. Haigh · 2021 · Frontiers in Microbiology
Development of antibody resistance in emerging mutant strains of SARS CoV‐2: Impediment for COVID‐19 vaccines
Narasimha Murthy Beeraka, Olga A. Sukocheva, Elena Lukina, Junqi Liu, Ruitai Fan · 2022 · Reviews in Medical Virology
Viral and cellular translation during SARS‐CoV‐2 infection
Gilbert Eriani, Franck Martin · 2022 · FEBS Open Bio
Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs
Neda Eskandarzade, Abozar Ghorbani, Samira Samarfard, José Dı́az, Pietro Hiram Guzzi, Niloofar Fariborzi, Ahmad Tahmasebi, K. Izadpanah · 2022 · Computers in Biology and Medicine
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins
Fengwen Zhang, Trinity M. Zang, Eva M. Stevenson, Xiao Lei, Dennis C. Copertino, Talia M. Mota, Julie Boucau, Wilfredo F. García-Beltrán, Richard Brad Jones, Paul D. Bieniasz · 2022 · Proceedings of the National Academy of Sciences
Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients
Sarah Cristina Gozzi-Silva, Luana de Mendonça Oliveira, Ricardo Wesley Alberca, Nátalli Zanete Pereira, Fábio Seiti Yamada Yoshikawa, Anna Julia Pietrobon, Tatiana Mina Yendo, Milena Mary de Souza Andrade, Yasmim Álefe Leuzzi Ramos, Cyro Alves de Brito et al. · 2022 · Cells
Astragaloside IV Regulates cGAS-STING Signaling Pathway to Alleviate Immunosuppression Caused by PRRSV Infection
Ke Song, Jiaying Yu, Jiang Li, Miao Li, Lu-Yuan Peng, Peng-Fei Yi · 2023 · Viruses
Secreted LRPAP1 binds and triggers IFNAR1 degradation to facilitate virus evasion from cellular innate immunity
Huangcan Li, Xiong Wang, Yiran Wang, Yichen Li, Ying Chen, Y. W. Wong, Jufang He, Ming‐Liang He · 2023 · Signal Transduction and Targeted Therapy
SARS-CoV-2 and the DNA damage response
Roger J.A. Grand · 2023 · Journal of General Virology
IKKɛ induces STING non-IFN immune responses via a mechanism analogous to TBK1
Rajan Venkatraman, Katherine R. Balka, Wilson Wong, Jananipriya Sivamani, Zoe Magill, Kirsteen McInnes Tullett, Rachael M. Lane, Tahnee L. Saunders, Maximilien Tailler, Peter John Crack et al. · 2024 · iScience
Interferon-stimulated genes and their antiviral activity against SARS-CoV-2
Ana Maria Ortega‐Prieto, Jose M. Jiménez-Guardeño · 2024 · mBio
T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
Samuele Notarbartolo · 2024 · Vaccines
Science's Response to CoVID‐19
Marcus J. C. Long, Yimon Aye · 2021 · ChemMedChem
Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19
Angelene M. Cantwell, Harinder Singh, Maryann P. Platt, Yanbao Yu, Yi-Han Lin, Yuji Ikeno, Gene B. Hubbard, Yan Xiang, Norberto González-Juarbe, Peter H. Dube · 2021 · Journal of Virology
SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways
Soo Jin Oh, Ok Sarah Shin · 2022 · The Journal of Microbiology
Translational Control of COVID-19 and Its Therapeutic Implication
Dejiu Zhang, Lei Zhu, Yin Wang, Peifeng Li, Yanyan Gao · 2022 · Frontiers in Immunology
Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters
Shu-Feng Liu, C. Stauft, Prabhuanand Selvaraj, P. Chandrasekaran, F. D'agnillo, Chao-Kai Chou, Wells W. Wu, Christopher Z. Lien, Clement A. Meseda, Cyntia L Pedro et al. · 2022 · Nature Communications
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
Gianmarco Bellucci, Angela Albanese, Caterina Rizzi, Virginia Rinaldi, Marco Salvetti, Giovanni Ristori · 2023 · Frontiers in Immunology
SARS‐CoV‐2 NSP13 interacts with host IRF3, blocking antiviral immune responses
K. Feng, Huijiao Zhang, Yuan-Qin Min, Min Zhou, F. Deng, Hua-Lin Wang, Pei-Qing Li, Yun-Jia Ning · 2023 · Journal of Medical Virology
EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8
Ying-Hua Zhao, Li-Yan Sui, Ping Wu, Le-Tian Li, Li Liu, Bao-Hua Ma, Wen-Fang Wang, Hongmiao Chi, Ze-Dong Wang, Zhengkai Wei et al. · 2023 · Journal of Virology
The African Swine Fever Virus Virulence Determinant DP96R Suppresses Type I IFN Production Targeting IRF3
Niranjan Dodantenna, Ji-Won Cha, Kiramage Chathuranga, W. A. Gayan Chathuranga, Asela Weerawardhana, Lakmal Ranathunga, Yongkwan Kim, Weon‐Hwa Jheong, Jong‐Soo Lee · 2024 · International Journal of Molecular Sciences
Nsp1 of SARS-CoV-2 stimulates host translation termination
Alexey V. Shuvalov, Ekaterina Shuvalova, Nikita Biziaev, Elizaveta Sokolova, Konstantin Evmenov, Nikolay Pustogarov, Aleksandra Arnautova, Vera A. Matrosova, Tatiana Egorova, Elena Z. Alkalaeva · 2021 · RNA Biology
N440K variant of SARS-CoV-2 has Higher Infectious Fitness
Dixit Tandel, Divya Gupta, Vishal Sah, Krishnan Harinivas Harshan · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Interactome profiling reveals interaction of SARS-CoV-2 NSP13 with host factor STAT1 to suppress interferon signaling
Kuan Feng, Yuan‐Qin Min, Xiulian Sun, Fēi Dèng, Peiqing Li, Huálín Wáng, Yun‐Jia Ning · 2021 · Journal of Molecular Cell Biology
Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium
Hong Guo Parke, Dermot A. Linden, Sinéad Weldon, Joseph C. Kidney, Clifford C. Taggart · 2022 · Medicina
The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy
Yiran Wang, Mandi Wu, Yichen Li, Ho Him Yuen, Ming‐Liang He · 2022 · Journal of Biomedical Science
Coronaviral Infection and Interferon Response: The Virus-Host Arms Race and COVID-19
Qi Liu, Sensen Chi, Kostyantyn V. Dmytruk, Olena V. Dmytruk, Shuai Tan · 2022 · Viruses
SARS-CoV-2 ORF8 accessory protein is a virulence factor
Melissa Belló-Pérez, Jesús Hurtado-Tamayo, Anna Z. Mykytyn, Mart Matthias Lamers, Ricardo Requena-Platek, Debby Schipper, Diego Muñoz‐Santos, Jorge Ripoll-Gómez, Ana Esteban, Pedro J. Sánchez‐Cordón et al. · 2023 · mBio
Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19
Chen-Tsung Huang, Tai‐Ling Chao, Han‐Chieh Kao, Yu-Hao Pang, Wen-Hau Lee, Chiao-Hui Hsieh, Sui‐Yuan Chang, Hsuan‐Cheng Huang, Hsueh‐Fen Juan · 2020 · Heliyon
What do we know about the function of SARS-CoV-2 proteins?
Santiago Justo Arévalo, Adriana Castillo Chávez, Carmen Sofia Uribe Calampa, Daniela Zapata Sifuentes, César J. Huallpa, Gianfranco Landa Bianchi, Romina Garavito-Salini Casas, Mauro Quiñones Aguilar, Roberto Pineda · 2023 · Frontiers in Immunology
Mucosal Immunity against SARS-CoV-2 in the Respiratory Tract
Hae Eun Noh, Min‐Seok Rha · 2024 · Pathogens
Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine –possible therapeutic implication
Mehrdad Ghashghaeinia, Peter Dreischer, Thomas Wieder, Martin Köberle · 2020 · Cell Cycle
Immune response to COVID-19 in older adults
Mladen Jergović, Christopher P. Coplen, Jennifer L. Uhrlaub, Janko Nikolich‐Žugich · 2021 · The Journal of Heart and Lung Transplantation
Coronavirus persistence in human respiratory tract and cell culture: An overview
Adriana Gaspar-Rodríguez, Ana Padilla-González, Evelyn Rivera-Toledo · 2021 · The Brazilian Journal of Infectious Diseases
Devil's tools: SARS-CoV-2 antagonists against innate immunity
Duo Xu, Mahamaya N. Biswal, Arrmund Neal, Rong Hai · 2021 · Current Research in Virological Science
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset
Jaclyn C. Law, Mélanie Girard, Gary Y. C. Chao, Lesley A. Ward, Baweleta Isho, Bhavisha Rathod, Karen Colwill, Zhijie Li, James M. Rini, Feng Yun Yue et al. · 2021 · The Journal of Immunology
Elucidating the role of N440K mutation in SARS-CoV-2 spike – ACE-2 binding affinity and COVID-19 severity by virtual screening, molecular docking and dynamics approach
Malathi Kullappan, Usha Mary, Jenifer Mallavarpu Ambrose, Vishnu Priya Veeraraghavan, Krishna Mohan Surapaneni · 2021 · Journal of Biomolecular Structure and Dynamics
Identifying enhancers of innate immune signaling as broad-spectrum antivirals active against emerging viruses
Ghizlane Maarifi, Marie France Martin, Abderezak Zebboudj, Aude Boulay, Pierre Nouaux, Juliette Fernandez, Justine Lagisquet, Dominique Garcin, Raphaël Gaudin, Nathalie Jane Arhel et al. · 2022 · Cell chemical biology
Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19
Laure‐Alix Clerbaux, Sally A. Mayasich, Amalia Muñoz, Helena Soares, Mauro Petrillo, Maria Cristina Albertini, Nicolas Lanthier, Lucia Grenga, Maria João Amorim · 2022 · Journal of Clinical Medicine
Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins
Yongxu Lu, Hendrik A. Michel, Pei‐Hui Wang, Geoffrey L. Smith · 2022 · Frontiers in Microbiology
Interferons—Implications in the Immune Response to Respiratory Viruses
Harrison C. Bergeron, Matthew R. Hansen, Ralph A. Tripp · 2023 · Microorganisms
Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5
Brian Imbiakha, Shahrzad Ezzatpour, David W. Buchholz, Julie Sahler, Chengjin Ye, Ximena A. Olarte‐Castillo, Anna Zou, Cole T. Kwas, Katelyn O’Hare, Annette Choi et al. · 2023 · Science Advances
SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction
Oyahida Khatun, Mansi Sharma, Rohan Narayan, Shashank Tripathi · 2023 · Cellular and Molecular Life Sciences
CRL4B E3 ligase recruited by PRPF19 inhibits SARS-CoV-2 infection by targeting ORF6 for ubiquitin-dependent degradation
Linran Zhang, Pengfei Hao, Xiang Chen, Shuai Lv, Wenying Gao, Chang Li, Zhaolong Li, Wenyan Zhang · 2024 · mBio
A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study
Pierre Fillâtre, Marie-José Dufour, Sylvie Behillil, Rémi Vatan, Pascale Reusse, Alice Gabellec, Nicolas Velmans, Catherine Montagne, Sophie Geffroy Du Coudret, Edith Droumaguet et al. · 2021 · Clinical Microbiology and Infection
A phylogeny-based metric for estimating changes in transmissibility from recurrent mutations in SARS-CoV-2
Damien Richard, Liam P. Shaw, Robert Lanfear, Russell B Corbett-Detig, Angie S. Hinrichs, Jakob McBroome, Yatish Turakhia, Mislav Acman, Christopher J. Owen, Cedric C.S. Tan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
COVID-19: Imbalanced Immune Responses and Potential Immunotherapies
Bing Xie, Jiancheng Zhang, Yuwen Li, Shiying Yuan, You Shang · 2021 · Frontiers in Immunology
An Update on Innate Immune Responses during SARS-CoV-2 Infection
Yu Long Zhang, Shuaiyin Chen, Yuefei Jin, Wangquan Ji, Weiguo Zhang, Guangcai Duan · 2021 · Viruses
A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicronin vivo
Daming Zuo, Yu Chen, Jian‐Piao Cai, Hao-Yang Yuan, Junqi Wu, Yue Yin, Jingwen Xie, Jingmin Lin, Jia Luo, Yang Feng et al. · 2022 · Protein & Cell
Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device
Woo Joo Kim, Christine C. Roberts, Joon Young Song, Jin Gu Yoon, Hye Seong, Hakjun Hyun, Hyojin Lee, Areum Gil, Yeeun Oh, Ji-Eun Park et al. · 2022 · International Journal of Infectious Diseases
Interaction of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicases DDX1 and DDX3X Modulates Their Activities on Double-Stranded RNA
Camilla Lodola, Massimiliano Secchi, Virginia Sinigiani, Antonella De Palma, Rossana Rossi, Davide Perico, Pierluigi Mauri, Giovanni Maga · 2023 · International Journal of Molecular Sciences
SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling
Blanca D. López‐Ayllón, Ana de Lucas‐Rius, Laura Mendoza‐García, Tránsito García‐García, Raúl Fernández‐Rodríguez, José M. Suárez-Cárdenas, Fátima Milhano Santos, Fernando José Corrales, Natalia Redondo, Federica Pedrucci et al. · 2023 · Frontiers in Immunology
Dynamical modelling of viral infection and cooperative immune protection in COVID-19 patients
Zhengqing Zhou, Dianjie Li, Ziheng Zhao, Shuyu Shi, Jianghua Wu, Jianwei Li, Jingpeng Zhang, Ke Gui, Yu Long Zhang, Qi Ouyang et al. · 2023 · PLoS Computational Biology
Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1
Ahmed Magdy Khalil, Aitor Nogales, Luis Martínez‐Sobrido, Ahmed Mostafa · 2024 · Frontiers in Cellular and Infection Microbiology
A systematic mutation analysis of 13 major SARS-CoV-2 variants
Han Bai, Xuan Zhang, Tian Gong, Junpeng Ma, Peng Zhang, Zeqiong Cai, Doudou Ren, Chengsheng Zhang · 2024 · Virus Research
TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication
María González-Orozco, Tseng Hsiang-Chi, Adam Hage, Hongjie Xia, Padmanava Behera, Kazi Sabrina Afreen, Yoatzin Peñaflor-Téllez, María I. Giraldo, Matthew B. Huante, Lucinda Puebla-Clark et al. · 2024 · Nature Communications
Insights into coronavirus immunity taught by the murine coronavirus
Sarah Grabherr, Burkhard Ludewig, Natalia Barbara Pikor · 2021 · European Journal of Immunology
Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats
Sahana Nagaraja, Disha Jain, Sannula Kesavardhana · 2021 · Journal of Leukocyte Biology
Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka
D.M.S.H.K. Ranasinghe, Deshni Jayathilaka, Chandima Jeewandara, Dumni Nadani Gunasinghe, Dinuka Ariyaratne, Tibutius T. P. Jayadas, Heshan Kuruppu, Ayesha Wijesinghe, Farha Bary, Deshan Madusanka et al. · 2022 · Frontiers in Public Health
COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us?
Claudio Giuseppe Gallo, Sirio Fiorino, Giovanni Posabella, Donato Antonacci, Antonio Tropeano, Emanuele Pausini, Carlotta Pausini, Tommaso Guarniero, Wandong Hong, Enrico Giampieri et al. · 2021 · Cytokine
An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity
Yamei Zhang, Siobhán Gargan, Yongxu Lu, Nigel J. Stevenson · 2021 · Viruses
Structural Analysis on the Severe Acute Respiratory Syndrome Coronavirus 2 Non-structural Protein 13 Mutants Revealed Altered Bonding Network With TANK Binding Kinase 1 to Evade Host Immune System
Farooq Rashid, Muhammad Suleman, Abdullah Shah, Emmanuel Enoch Dzakah, Shuyi Chen, Haiying Wang, Shixing Tang · 2021 · Frontiers in Microbiology
Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells
Yamei Zhang, Siobhán Gargan, Fiona M. Roche, Matthew B. Frieman, Nigel J. Stevenson · 2022 · Viruses
Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism
Hoi Tong Wong, Victoria Cheung, Daniel J. Salamango · 2022 · Journal of Cell Science
Retinoic Acid–Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection
Lara S. U. Schwab, Rubaiyea Farrukee, Jean‐François Eléouët, Marie‐Anne Rameix‐Welti, Sarah L. Londrigan, Andrëw G. Brööks, Aeron C. Hurt, Christoph Coch, Thomas Zillinger, Gunther Hartmann et al. · 2022 · The Journal of Infectious Diseases
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice
Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, Ethan J. Fritch, James A. Levi, Nicole J. Johnson, Frank Scholle, Lakshmanane Premkumar, Brett L. Hurst, Felipe Lee-Montiel et al. · 2022 · ACS Omega
Progress of cGAS-STING signaling in response to SARS-CoV-2 infection
Yaru Wu, Min Zhang, Cui Yuan, Zhenling Ma, Wenqing Li, Yanyan Zhang, Lijuan Su, Jun Chen Xu, Wei Liu · 2022 · Frontiers in Immunology
Porcine Epidemic Diarrhea Virus nsp7 Inhibits MDA5 Dephosphorylation to Antagonize Type I Interferon Production
Jiansong Zhang, Puxian Fang, Jie Ren, Sijin Xia, Huichang Zhang, Xuerui Zhu, Tong Ding, Shaobo Xiao, Liurong Fang · 2023 · Microbiology Spectrum
SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
Alessandra Sacchi, Flavia Giannessi, Andrea Sabatini, Zulema Antonia Percario, Elisabetta Affabris · 2023 · International Journal of Molecular Sciences
The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactions
Dimitriya Hristoforova Garvanska, R. Elias Alvarado, Filip Oskar Mundt, Richard Lindqvist, Josephine Kerzel Duel, Fabian Coscia, Emma Nilsson, Kumari G. Lokugamage, Bryan A. Johnson, Jessica A. Plante et al. · 2024 · EMBO Reports
SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles
Tarun Kumar Mishra, M Sreepadmanabh, Pavitra Ramdas, Amit K Sahu, Atul Kumar, Ajit G. Chande · 2021 · Frontiers in Cellular and Infection Microbiology
STAT1 N-terminal domain discriminatively controls type I and type II IFN signaling
Anja Göder, Torsten Ginter, Thorsten Heinzel, Svenja Stroh, Jörg Fahrer, Andreas Henke, Oliver Holger Krämer · 2021 · Cytokine
Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin
Sameer-ul-Salam Mattoo, Seong‐Jun Kim, Dae‐Gyun Ahn, Jinjong Myoung · 2022 · Viruses
Identification of serum metabolites enhancing inflammatory responses in COVID-19
Chen-Song Zhang, Bing-Chang Zhang, Meng-Qi Li, Xiaoyan Wei, Kai Gong, Zhi-Yong Li, Xiangyang Yao, Jianfeng Wu, Ci-Xiong Zhang, Mingxia Zhu et al. · 2022 · Science China Life Sciences
Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19
Doris Loh, Russel Joseph Reiter · 2022 · International Journal of Molecular Sciences
Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
Jesús Hurtado-Tamayo, Ricardo Requena-Platek, Luis Enjuanes, Melissa Belló-Pérez, Isabel Sola · 2023 · Frontiers in Cellular and Infection Microbiology
SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells
Gianni Gori Savellini, Gabriele Anichini, Maria Grazia Cusi · 2023 · Virus Research
Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities
Ioanna E. Galani, Evangelos Andreakos · 2021 · Seminars in Immunology
SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis
Agnese Gugliandolo, Luigi Chiricosta, Valeria Calcaterra, Mara Biasin, Gioia Cappelletti, Stephana Carelli, Gianvincenzo Zuccotti, Maria Antonietta Avanzini, Placido Bramanti, Glória Pelizzo et al. · 2021 · International Journal of Molecular Sciences
Construction and characterization of two SARS‐CoV‐2 minigenome replicon systems
Hu Zhang, Douglas K. Fischer, Masahiro Shuda, Patrick S. Moore, Shou‐Jiang Gao, Zandrea Ambrose, Haitao Guo · 2022 · Journal of Medical Virology
SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection
Minghua Li, Kasirajan Ayyanathan, Mark Dittmar, Jesse Miller, Iulia Tapescu, Jae Seung Lee, Marisa E. McGrath, Yong Xue, Sanjay Vashee, D. Schultz et al. · 2023 · mBio
Serum levels of type I interferon (IFN-I) is associated with the severity of COVID-19
Yuting Sun, Gang Wang, Rongshuai Wang, Liang Ren, Zilin Yuan, Yueping Liu, Yuzhang Wu, Rong Chen, Yongwen Chen, Bo Diao · 2023 · Journal of Medical Microbiology
High-resolution kinetic characterization of the RIG-I-signaling pathway and the antiviral response
Sandy S. Burkart, Darius Schweinoch, Jamie Frankish, Carola Sparn, Sandra Wüst, Christian Urban, Marta Merlo, Vladimir Gonçalves Magalhães, Antonio Piras, Andreas Pichlmair et al. · 2023 · Life Science Alliance
Differences and similarities between innate immune evasion strategies of human coronaviruses
Helene Hoenigsperger, Rinu Sivarajan, Konstantin M. J. Sparrer · 2024 · Current Opinion in Microbiology
RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm?
Sophia K. Stegeman, Olena Kourko, Heather Amsden, Isabella E. Pellizzari-Delano, John E. Mamatis, Madison Roth, Che C. Colpitts, Katrina Gee · 2025 · Journal of Innate Immunity
The Many Faces of Innate Immunity in SARS-CoV-2 Infection
Nicholas Hanan, Ronnie L. Doud, In-Woo Park, Harlan P. Jones, Stephen O. Mathew · 2021 · Vaccines
Know your enemy and know yourself – the case of SARS-CoV-2 host factors
Wai Suet Lee, Meisam Yousefi, Biaoguo Yan, Cythia Lingli Yong, Yaw Shin Ooi · 2021 · Current Opinion in Virology
Clash of the titans: interferons and SARS-CoV-2
Nolwenn Jouvenet, Caroline Goujon, Arinjay Banerjee · 2021 · Trends in Immunology